4.7 Article

Antimicrobial-Sensing Proteins in Obesity and Type 2 Diabetes The buffering efficiency hypothesis

Journal

DIABETES CARE
Volume 34, Issue -, Pages S335-S341

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/dc11-s238

Keywords

-

Funding

  1. Ministerio de Educacion y Ciencia [SAF2008-02073]
  2. AstraZeneca
  3. Boehringer Ingelheim
  4. Bristol-Myers Squibb
  5. Daiichi Sankyo
  6. Eli Lilly
  7. Ethicon Endo-Surgery
  8. Generex Biotechnology
  9. F. Hoffmann-La Roche
  10. Janssen-Cilag
  11. Johnson Johnson
  12. Novo Nordisk
  13. Medtronic
  14. Pfizer

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available